Compare NRXP & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXP | NMS |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.8M | 71.0M |
| IPO Year | N/A | N/A |
| Metric | NRXP | NMS |
|---|---|---|
| Price | $2.28 | $11.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.67 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 12.0K |
| Earning Date | 11-17-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $242,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $847.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.58 | $9.21 |
| 52 Week High | $4.48 | $12.18 |
| Indicator | NRXP | NMS |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 49.98 |
| Support Level | $2.00 | $11.55 |
| Resistance Level | $2.48 | $11.98 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 35.95 | 58.33 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.